ACADIA Pharmaceuticals (ACAD) News Today $25.32 -0.42 (-1.63%) Closing price 04:00 PM EasternExtended Trading$25.32 0.00 (0.00%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACAD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Acadia Pharmaceuticals Appoints Konstantina Katcheves as Senior Vice President, Chief Business and Strategy Officer4 hours ago | businesswire.comACADIA Pharmaceuticals Inc. $ACAD Shares Bought by American Century Companies Inc.August 25 at 3:55 AM | marketbeat.comRussell Investments Group Ltd. Purchases 43,523 Shares of ACADIA Pharmaceuticals Inc. $ACADAugust 25 at 3:42 AM | marketbeat.com11,832 Shares in ACADIA Pharmaceuticals Inc. $ACAD Bought by Cetera Investment AdvisersAugust 25 at 3:02 AM | marketbeat.comCharles Schwab Investment Management Inc. Decreases Position in ACADIA Pharmaceuticals Inc. $ACADAugust 24 at 3:18 AM | marketbeat.comACADIA Pharmaceuticals (NASDAQ:ACAD) EVP Mark Schneyer Sells 22,000 SharesAugust 21, 2025 | marketbeat.comAlgert Global LLC Sells 136,200 Shares of ACADIA Pharmaceuticals Inc. $ACADAugust 21, 2025 | marketbeat.comSaniona and Jazz Pharmaceuticals Ink Licensing Deal for Epilepsy TreatmentAugust 20, 2025 | msn.comMark Schneyer Sells 22,000 Shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) StockAugust 20, 2025 | insidertrades.comNuveen LLC Takes $21.63 Million Position in ACADIA Pharmaceuticals Inc. $ACADAugust 20, 2025 | marketbeat.comVanguard Group Inc. Buys 1,255,594 Shares of ACADIA Pharmaceuticals Inc. $ACADAugust 20, 2025 | marketbeat.comPublic Sector Pension Investment Board Purchases Shares of 390,431 ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)August 18, 2025 | marketbeat.comAnalysts Set ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Target Price at $28.88August 18, 2025 | americanbankingnews.comWall Street Zen Upgrades ACADIA Pharmaceuticals (NASDAQ:ACAD) to "Buy"August 17, 2025 | marketbeat.comDeutsche Bank AG Has $12.63 Million Stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)August 16, 2025 | marketbeat.comACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives Average Rating of "Moderate Buy" from AnalystsAugust 16, 2025 | marketbeat.comHigh Growth Tech Stocks To Watch In The US August 2025August 15, 2025 | uk.finance.yahoo.comMaryland State Retirement & Pension System Makes New $597,000 Investment in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)August 15, 2025 | marketbeat.comShareholders In ACADIA Pharmaceuticals (NASDAQ:ACAD) Should Look Beyond Earnings For The Full StoryAugust 14, 2025 | finance.yahoo.comMutual of America Capital Management LLC Acquires Shares of 17,930 ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)August 14, 2025 | marketbeat.comACADIA Pharmaceuticals (NASDAQ:ACAD) Hits New 1-Year High - Here's What HappenedAugust 13, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Decreases Stock Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)August 13, 2025 | marketbeat.comAnalysts Are Bullish on Top Healthcare Stocks: Vertex Pharmaceuticals (VRTX), AMN Healthcare Services (AMN)August 13, 2025 | theglobeandmail.comHeadlands Technologies LLC Sells 34,916 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)August 12, 2025 | marketbeat.comNeedham Keeps Their Buy Rating on Avadel Pharmaceuticals (AVDL)August 12, 2025 | theglobeandmail.comResults: ACADIA Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its EstimatesAugust 11, 2025 | finance.yahoo.comAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 11, 2025 | businesswire.comNatixis Advisors LLC Increases Stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)August 11, 2025 | marketbeat.comHC Wainwright Issues Optimistic Forecast for ACAD EarningsAugust 11, 2025 | marketbeat.comACADIA Pharmaceuticals (NASDAQ:ACAD) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPSAugust 10, 2025 | marketbeat.comEquities Analysts Offer Predictions for ACAD FY2027 EarningsAugust 9, 2025 | marketbeat.comLeerink Partnrs Has Pessimistic View of ACAD FY2025 EarningsAugust 9, 2025 | marketbeat.comACADIA Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats ExpectationsAugust 9, 2025 | finance.yahoo.comACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Raised to $17.00 at The Goldman Sachs GroupAugust 8, 2025 | marketbeat.comACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Expected to Rise, Royal Bank Of Canada Analyst SaysAugust 8, 2025 | marketbeat.comMizuho Issues Positive Forecast for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock PriceAugust 8, 2025 | marketbeat.comJMP Securities Issues Positive Forecast for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock PriceAugust 8, 2025 | marketbeat.comACADIA Pharmaceuticals Inc. (ACAD) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comAcadia Pharma Q2 2025 Earnings PreviewAugust 7, 2025 | seekingalpha.comAcadia raises 2025 NUPLAZID guidance to $665M–$690M as DAYBUE accelerates community uptakeAugust 7, 2025 | seekingalpha.comACADIA Pharmaceuticals Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 7, 2025 | seekingalpha.comAcadia (ACAD) Q2 Revenue Rises 9%August 6, 2025 | fool.comAcadia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operating OverviewAugust 6, 2025 | businesswire.comAcadia Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth ConferenceAugust 5, 2025 | businesswire.com407,051 Shares in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Purchased by Jupiter Asset Management Ltd.August 5, 2025 | marketbeat.comAcadia Pharmaceuticals Appoints Scott Cenci as Chief Information and Data OfficerAugust 4, 2025 | businesswire.com16,224 Shares in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Purchased by Pacer Advisors Inc.August 3, 2025 | marketbeat.comACAD - ACADIA Pharmaceuticals Inc Key Metrics | MorningstarAugust 1, 2025 | morningstar.comMUniversal Beteiligungs und Servicegesellschaft mbH Purchases Shares of 106,896 ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)August 1, 2025 | marketbeat.comY Intercept Hong Kong Ltd Sells 18,378 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)August 1, 2025 | marketbeat.com Get ACADIA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ACAD and its competitors with MarketBeat's FREE daily newsletter. Email Address ACAD Media Mentions By Week ACAD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACAD News Sentiment▼1.040.71▲Average Medical News Sentiment ACAD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACAD Articles This Week▼1110▲ACAD Articles Average Week Get ACADIA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ACAD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Genmab A/S News Viatris News Dr. Reddy's Laboratories News Ascendis Pharma A/S News Moderna News Qiagen News BridgeBio Pharma News Verona Pharma PLC American Depositary Share News Elanco Animal Health News Blueprint Medicines News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACAD) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ACADIA Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ACADIA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access